Anlon Healthcare, a company in the Pharmaceuticals industry, reported revenue of ₹106 crore and net profit of ₹17 crore for the September 2026 quarter.
Anlon Healthcare (NSE: AHCL) closed at ₹25.17 on 20 Nov 2026, up 61.0% over the past year. Its market capitalisation is ₹1,338 crore and it trades at 37.5 times earnings.
Incorporated in 2013, Anlon Healthcare Limited is a chemical manufacturing company engaged in the manufacturing of Pharma Intermediates and active pharmaceutical ingredients (APIs).
Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.